Report Cover

Global Opioid Use Disorder Market Research Report 2022


Opioid Use Disorder market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Opioid Use Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Buprenorphine
    Methadone
    Naltrexone
Segment by Application
    Moderate Pain Treatment
    Severe Pain Treatment
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Indivior
    Alkermes
    Titan Pharmaceuticals
    Hikma Pharmaceuticals
    Teva Pharmaceuticals
    MediciNova
    Orexo
    Camurus
    Omeros
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Buprenorphine
        1.2.3 Methadone
        1.2.4 Naltrexone
    1.3 Market by Application
        1.3.1 Global Opioid Use Disorder Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Moderate Pain Treatment
        1.3.3 Severe Pain Treatment
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Opioid Use Disorder Market Perspective (2017-2028)
    2.2 Opioid Use Disorder Growth Trends by Region
        2.2.1 Opioid Use Disorder Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Opioid Use Disorder Historic Market Size by Region (2017-2022)
        2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2023-2028)
    2.3 Opioid Use Disorder Market Dynamics
        2.3.1 Opioid Use Disorder Industry Trends
        2.3.2 Opioid Use Disorder Market Drivers
        2.3.3 Opioid Use Disorder Market Challenges
        2.3.4 Opioid Use Disorder Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Opioid Use Disorder Players by Revenue
        3.1.1 Global Top Opioid Use Disorder Players by Revenue (2017-2022)
        3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2017-2022)
    3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
    3.4 Global Opioid Use Disorder Market Concentration Ratio
        3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2021
    3.5 Opioid Use Disorder Key Players Head office and Area Served
    3.6 Key Players Opioid Use Disorder Product Solution and Service
    3.7 Date of Enter into Opioid Use Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Use Disorder Breakdown Data by Type
    4.1 Global Opioid Use Disorder Historic Market Size by Type (2017-2022)
    4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028)
5 Opioid Use Disorder Breakdown Data by Application
    5.1 Global Opioid Use Disorder Historic Market Size by Application (2017-2022)
    5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Opioid Use Disorder Market Size (2017-2028)
    6.2 North America Opioid Use Disorder Market Size by Country (2017-2022)
    6.3 North America Opioid Use Disorder Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Opioid Use Disorder Market Size (2017-2028)
    7.2 Europe Opioid Use Disorder Market Size by Country (2017-2022)
    7.3 Europe Opioid Use Disorder Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Opioid Use Disorder Market Size (2017-2028)
    8.2 Asia-Pacific Opioid Use Disorder Market Size by Country (2017-2022)
    8.3 Asia-Pacific Opioid Use Disorder Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Opioid Use Disorder Market Size (2017-2028)
    9.2 Latin America Opioid Use Disorder Market Size by Country (2017-2022)
    9.3 Latin America Opioid Use Disorder Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Opioid Use Disorder Market Size (2017-2028)
    10.2 Middle East & Africa Opioid Use Disorder Market Size by Country (2017-2022)
    10.3 Middle East & Africa Opioid Use Disorder Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Indivior
        11.1.1 Indivior Company Detail
        11.1.2 Indivior Business Overview
        11.1.3 Indivior Opioid Use Disorder Introduction
        11.1.4 Indivior Revenue in Opioid Use Disorder Business (2017-2022)
        11.1.5 Indivior Recent Development
    11.2 Alkermes
        11.2.1 Alkermes Company Detail
        11.2.2 Alkermes Business Overview
        11.2.3 Alkermes Opioid Use Disorder Introduction
        11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2017-2022)
        11.2.5 Alkermes Recent Development
    11.3 Titan Pharmaceuticals
        11.3.1 Titan Pharmaceuticals Company Detail
        11.3.2 Titan Pharmaceuticals Business Overview
        11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
        11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.3.5 Titan Pharmaceuticals Recent Development
    11.4 Hikma Pharmaceuticals
        11.4.1 Hikma Pharmaceuticals Company Detail
        11.4.2 Hikma Pharmaceuticals Business Overview
        11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
        11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.4.5 Hikma Pharmaceuticals Recent Development
    11.5 Teva Pharmaceuticals
        11.5.1 Teva Pharmaceuticals Company Detail
        11.5.2 Teva Pharmaceuticals Business Overview
        11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
        11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
        11.5.5 Teva Pharmaceuticals Recent Development
    11.6 MediciNova
        11.6.1 MediciNova Company Detail
        11.6.2 MediciNova Business Overview
        11.6.3 MediciNova Opioid Use Disorder Introduction
        11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2017-2022)
        11.6.5 MediciNova Recent Development
    11.7 Orexo
        11.7.1 Orexo Company Detail
        11.7.2 Orexo Business Overview
        11.7.3 Orexo Opioid Use Disorder Introduction
        11.7.4 Orexo Revenue in Opioid Use Disorder Business (2017-2022)
        11.7.5 Orexo Recent Development
    11.8 Camurus
        11.8.1 Camurus Company Detail
        11.8.2 Camurus Business Overview
        11.8.3 Camurus Opioid Use Disorder Introduction
        11.8.4 Camurus Revenue in Opioid Use Disorder Business (2017-2022)
        11.8.5 Camurus Recent Development
    11.9 Omeros
        11.9.1 Omeros Company Detail
        11.9.2 Omeros Business Overview
        11.9.3 Omeros Opioid Use Disorder Introduction
        11.9.4 Omeros Revenue in Opioid Use Disorder Business (2017-2022)
        11.9.5 Omeros Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Buprenorphine Table 3. Key Players of Methadone Table 4. Key Players of Naltrexone Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Opioid Use Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Opioid Use Disorder Market Share by Region (2017-2022) Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Opioid Use Disorder Market Share by Region (2023-2028) Table 11. Opioid Use Disorder Market Trends Table 12. Opioid Use Disorder Market Drivers Table 13. Opioid Use Disorder Market Challenges Table 14. Opioid Use Disorder Market Restraints Table 15. Global Opioid Use Disorder Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Opioid Use Disorder Market Share by Players (2017-2022) Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021) Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Opioid Use Disorder Product Solution and Service Table 22. Date of Enter into Opioid Use Disorder Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2017-2022) Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2023-2028) Table 28. Global Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2017-2022) Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2023-2028) Table 32. North America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Opioid Use Disorder Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million) Table 42. Indivior Company Detail Table 43. Indivior Business Overview Table 44. Indivior Opioid Use Disorder Product Table 45. Indivior Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 46. Indivior Recent Development Table 47. Alkermes Company Detail Table 48. Alkermes Business Overview Table 49. Alkermes Opioid Use Disorder Product Table 50. Alkermes Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 51. Alkermes Recent Development Table 52. Titan Pharmaceuticals Company Detail Table 53. Titan Pharmaceuticals Business Overview Table 54. Titan Pharmaceuticals Opioid Use Disorder Product Table 55. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 56. Titan Pharmaceuticals Recent Development Table 57. Hikma Pharmaceuticals Company Detail Table 58. Hikma Pharmaceuticals Business Overview Table 59. Hikma Pharmaceuticals Opioid Use Disorder Product Table 60. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 61. Hikma Pharmaceuticals Recent Development Table 62. Teva Pharmaceuticals Company Detail Table 63. Teva Pharmaceuticals Business Overview Table 64. Teva Pharmaceuticals Opioid Use Disorder Product Table 65. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 66. Teva Pharmaceuticals Recent Development Table 67. MediciNova Company Detail Table 68. MediciNova Business Overview Table 69. MediciNova Opioid Use Disorder Product Table 70. MediciNova Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 71. MediciNova Recent Development Table 72. Orexo Company Detail Table 73. Orexo Business Overview Table 74. Orexo Opioid Use Disorder Product Table 75. Orexo Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 76. Orexo Recent Development Table 77. Camurus Company Detail Table 78. Camurus Business Overview Table 79. Camurus Opioid Use Disorder Product Table 80. Camurus Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 81. Camurus Recent Development Table 82. Omeros Company Detail Table 83. Omeros Business Overview Table 84. Omeros Opioid Use Disorder Product Table 85. Omeros Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million) Table 86. Omeros Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid Use Disorder Market Share by Type: 2021 VS 2028 Figure 2. Buprenorphine Features Figure 3. Methadone Features Figure 4. Naltrexone Features Figure 5. Global Opioid Use Disorder Market Share by Application in 2021 & 2028 Figure 6. Moderate Pain Treatment Case Studies Figure 7. Severe Pain Treatment Case Studies Figure 8. Opioid Use Disorder Report Years Considered Figure 9. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Opioid Use Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Opioid Use Disorder Market Share by Region: 2021 VS 2028 Figure 12. Global Opioid Use Disorder Market Share by Players in 2021 Figure 13. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2021 Figure 15. North America Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Opioid Use Disorder Market Share by Country (2017-2028) Figure 17. United States Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Opioid Use Disorder Market Share by Country (2017-2028) Figure 21. Germany Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Opioid Use Disorder Market Share by Region (2017-2028) Figure 29. China Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Opioid Use Disorder Market Share by Country (2017-2028) Figure 37. Mexico Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Opioid Use Disorder Market Share by Country (2017-2028) Figure 41. Turkey Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 44. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 45. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 48. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 49. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 50. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 51. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us